Table 1 Physical and biochemical features of the total sample and comparison analysis
From: Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients
Cases N = 19 | Control group N = 19 | p | |
|---|---|---|---|
AGE | 11.94 ± 0.52 | 9.32 ± 0.96 | 0.041 |
BMI | 30.04 ± 0.98 | 15.96 ± 0.40 | 0.000 |
WTHR | 0.66 ± 0.80 | 0.38 ± 1.20 | 0.000 |
SBP | 121.87 ± 2.42 | 104.50 ± 4.50 | 0.070 |
DBP | 67.55 ± 1.84 | 65.11 ± 2.70 | 0.821 |
TC mg/dl | 175.52 ± 6.37 | 157.50 ± 11.56 | 0.194 |
TG mg/dl | 104.45 ± 5.95 | 79.40 ± 13.70 | 0.093 |
HDL mg/dl | 47.26 ± 2.26 | 57.70 ± 6.80 | 0.015 |
LDL mg/dl | 100.50 ± 7.27 | 75.46 ± 5.40 | 0.000 |
N-HDL mg/dl | 120.48 ± 8.07 | 76.80 ± 6.70 | 0.000 |
GLUCOSE mg/dl | 82.28 ± 1.71 | 86.86 ± 2.38 | 0.143 |
INSULIN μU/ml | 20.97 ± 1.73 | 9.90 ± 1.44 | 0.023 |
HOMA | 4.39 ± 0.42 | 2.16 ± 0.42 | 0.045 |
AST U/L | 25.27 ± 2.48 | 24.00 ± 2.70 | 0.586 |
ALT U/L | 28.24 ± 4.63 | 14.13 ± 1.91 | 0.048 |
AST/ALT U/L | 1.17 ± 0.11 | 1.75 ± 0.11 | 0.003 |
GGT U/L | 17.53 ± 2.18 | 13.00 ± 2.08 | 0.366 |
ENDOCAN ng/ml | 2.03 ± 0.15 | 1.51 ± 0.12 | 0.022 |